Voyager Therapeutics (VYGR) Interest & Investment Income (2015 - 2026)
Voyager Therapeutics (VYGR) posted Interest & Investment Income of -$295000.0 for Q1 2026, down 1280.0% sequentially from $25000.0 in Q4 2025, and down 241.83% YoY from $208000.0 in Q1 2025.
Voyager Therapeutics (VYGR) Interest & Investment Income (2015 - 2026) Analysis & Trends
Voyager Therapeutics has reported Interest & Investment Income for 12 years, with the latest figure at -$295000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 241.83% year-over-year to -$295000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$64000.0 (down 120.85% YoY) and the FY2025 annual result came in at $439000.0, up 222.28% from the prior year.
- Interest & Investment Income slipped to -$295000.0 in Q1 2026 per VYGR's latest filing, from $25000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $489000.0 in Q3 2024 and troughed at -$458000.0 in Q1 2024.
- A 5-year average of -$7352.9 and a median of -$1000.0 in 2023 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 1450.0% in 2022, down 4600.0% in 2022.
- Over 5 years, Interest & Investment Income stood at $118000.0 in 2022, then surged by 69.49% to $200000.0 in 2023, then sank by 287.0% to -$374000.0 in 2024, then surged by 106.68% to $25000.0 in 2025, then plunged by 1280.0% to -$295000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered -$295000.0, $25000.0, and $228000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Voyager Therapeutics | 205.86 Mn | 89.52 Mn | - | 1.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -158,000.00 |
| Mar 31, 2026 | -295,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | -22,000.00 |
| Mar 31, 2025 | 208,000.00 |
| Dec 31, 2024 | -374,000.00 |
| Sep 30, 2024 | 489,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -458,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | -115,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | 87,000.00 |
| Dec 31, 2022 | 118,000.00 |
| Sep 30, 2022 | 27,000.00 |
| Jun 30, 2022 | -141,000.00 |
| Mar 31, 2022 | -85,000.00 |
| Dec 31, 2021 | -10,000.00 |
| Sep 30, 2021 | -2,000.00 |